389 related articles for article (PubMed ID: 31977315)
1. Liraglutide and sitagliptin counter beta- to alpha-cell transdifferentiation in diabetes.
Tanday N; Flatt PR; Irwin N; Moffett RC
J Endocrinol; 2020 Apr; 245(1):53-64. PubMed ID: 31977315
[TBL] [Abstract][Full Text] [Related]
2. Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance.
Tanday N; Irwin N; Flatt PR; Moffett RC
Biochem Pharmacol; 2020 Jul; 177():114009. PubMed ID: 32360307
[TBL] [Abstract][Full Text] [Related]
3. Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells.
Mohan S; Lafferty R; Tanday N; Flatt PR; Moffett RC; Irwin N
PLoS One; 2021; 16(12):e0261608. PubMed ID: 34929019
[TBL] [Abstract][Full Text] [Related]
4. Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice.
Lafferty RA; Tanday N; Moffett RC; Reimann F; Gribble FM; Flatt PR; Irwin N
Front Endocrinol (Lausanne); 2021; 12():633625. PubMed ID: 33716983
[TBL] [Abstract][Full Text] [Related]
5. Enzymatically stable analogue of the gut-derived peptide xenin on beta-cell transdifferentiation in high fat fed and insulin-deficient Ins1
Tanday N; Moffett RC; Gault VA; Flatt PR; Irwin N
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3384. PubMed ID: 32662136
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic Glu
Sarnobat D; Moffett RC; Gault VA; Tanday N; Reimann F; Gribble FM; Flatt PR; Irwin N
Peptides; 2020 Mar; 125():170205. PubMed ID: 31738969
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic drug therapy alleviates type 1 diabetes in mice by promoting pancreatic α-cell transdifferentiation.
Sarnobat D; Moffett CR; Tanday N; Reimann F; Gribble FM; Flatt PR; Tarasov AI
Biochem Pharmacol; 2020 Dec; 182():114216. PubMed ID: 32926875
[TBL] [Abstract][Full Text] [Related]
8. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice.
Fan M; Jiang H; Zhang Y; Ma Y; Li L; Wu J
Med Sci Monit; 2018 Apr; 24():2310-2316. PubMed ID: 29664069
[TBL] [Abstract][Full Text] [Related]
10. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
[TBL] [Abstract][Full Text] [Related]
11. Beneficial actions of a long-acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation.
Tanday N; Irwin N; Moffett RC; Flatt PR; O'Harte FPM
Diabetes Obes Metab; 2020 Dec; 22(12):2468-2478. PubMed ID: 32844576
[TBL] [Abstract][Full Text] [Related]
12. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes.
Moffett RC; Patterson S; Irwin N; Flatt PR
Diabetes Metab Res Rev; 2015 Mar; 31(3):248-55. PubMed ID: 25256010
[TBL] [Abstract][Full Text] [Related]
13. Effects of artemether on pancreatic islet morphology, islet cell turnover and α-cell transdifferentiation in insulin-deficient GluCreERT2;ROSA26-eYFP diabetic mice.
Sarnobat D; Lafferty RA; Charlotte Moffett R; Tarasov AI; Flatt PR; Irwin N
J Pharm Pharmacol; 2022 Nov; 74(12):1758-1764. PubMed ID: 36206181
[TBL] [Abstract][Full Text] [Related]
14. Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets.
Wang MY; Dean ED; Quittner-Strom E; Zhu Y; Chowdhury KH; Zhang Z; Zhao S; Li N; Ye R; Lee Y; Zhang Y; Chen S; Yu X; Leonard DC; Poffenberger G; Von Deylen A; McCorkle SK; Schlegel A; Sloop KW; Efanov AM; Gimeno RE; Scherer PE; Powers AC; Unger RH; Holland WL
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619103
[TBL] [Abstract][Full Text] [Related]
15. Weight Loss-Independent Effect of Liraglutide on Insulin Sensitivity in Individuals With Obesity and Prediabetes.
Mashayekhi M; Nian H; Mayfield D; Devin JK; Gamboa JL; Yu C; Silver HJ; Niswender K; Luther JM; Brown NJ
Diabetes; 2024 Jan; 73(1):38-50. PubMed ID: 37874653
[TBL] [Abstract][Full Text] [Related]
16. Beneficial metabolic effects of recurrent periods of beta-cell rest and stimulation using stable neuropeptide Y1 and glucagon-like peptide-1 receptor agonists.
Tanday N; Lafferty RA; Flatt PR; Irwin N
Diabetes Obes Metab; 2022 Dec; 24(12):2353-2363. PubMed ID: 35848461
[TBL] [Abstract][Full Text] [Related]
17. Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage.
Mohan S; Lafferty RA; Flatt PR; Moffett RC; Irwin N
Peptides; 2022 Jun; 152():170772. PubMed ID: 35202749
[TBL] [Abstract][Full Text] [Related]
18. Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP mice.
Tanday N; Coulter-Parkhill A; Moffett RC; Suruli K; Dubey V; Flatt PR; Irwin N
J Endocrinol; 2023 Nov; 259(2):. PubMed ID: 37650517
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide regulates the viability of pancreatic α-cells and pancreatic β-cells through cAMP-PKA signal pathway.
Xu X; Chen J; Hu L; Liang M; Wang X; Feng S; Shen J; Luan X
Life Sci; 2018 Feb; 195():87-94. PubMed ID: 29225111
[TBL] [Abstract][Full Text] [Related]
20. Glutamine up-regulates pancreatic sodium-dependent neutral aminoacid transporter-2 and mitigates islets apoptosis in diabetic rats.
Medras ZJH; El-Sayed NM; Zaitone SA; Toraih EA; Sami MM; Moustafa YM
Pharmacol Rep; 2018 Apr; 70(2):233-242. PubMed ID: 29475006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
